Water-based Activity to Enhance Recall in Veterans (WATER-VET)

April 16, 2024 updated by: VA Office of Research and Development

Water-based Activities to Enhance Recall in Veterans (WATER-VET)

This two-year study will evaluate the feasibility of an exercise training augmentation for cognitive training intervention to improve memory performance in Veterans with a diagnosis of amnestic Mild Cognitive Impairment (aMCI). This is a two-phased trial: 1) an exercise phase and 2) a cognitive training program. The exercise phase will be an aquatic based exercise program. A combination of exercise and cognitive training programs designed for persons without cognitive impairment have significantly improved memory more than other single intervention groups (exercise only, cognitive training only) and given the success of combination training programs with healthy older adults, it is important to adapt these programs for persons beginning to exhibit clinically significant memory problems, such as those with aMCI.

Study Overview

Status

Completed

Detailed Description

The primary research question of the proposed study is this: Is a combination water-based physical exercise + cognitive training program for older Veterans with amnestic Mild Cognitive Impairment (MCI) feasible? The primary aims of the proposed research are: 1) demonstrate adequate recruitment and retention rates; 2) refinement of inclusion/exclusion criteria; and 3) further refine the combination waterbased physical exercise + cognitive training (WATER+CT) intervention.

These aims will be tested in a two-phase clinical trial with a single group design: 1) exercise training phase and 2) a cognitive training phase. The exercise training phase consists of a water-based physical exercise program that emphasizes cardiovascular fitness and strength training through a combination of non-weight bearing exercises that include land-based stretching and water-based activities. This 2-year pilot project will include 50 Veterans diagnosed with amnestic MCI age 50-90. The exercise component consists of a six-month water-based exercise program followed by a four-week cognitive training program. For the first two months of the water-based exercise program, Veterans will come to thrice-weekly group sessions at Aquatic Therapy Center at the VA Palo Alto Health Care System. This will transition to a self-paced exercise program for the remaining four months. After completion of the exercise program, Veterans will begin classroom-based cognitive training at the VA Palo Alto Health Care System (VAPAHCS). The cognitive training is based on an efficacious cognitive program that is structured around two components, pre-training and mnemonic training, both of which have been used successfully in persons with aMCI. Assessments of adherence will be administered throughout treatment and measures of feasibility will be completed post-treatment.

Participants will complete a variety of neuropsychological measures taping into areas of cognition such as attention, executive functioning, and memory. To study possible predictors of treatment response, the investigators will also collect biological (cardiovascular functioning and brain derived neurotrophic factor [BDNF] plasma levels) and genetic data (APOE and BDNF genotypes) from these participants. The investigators hope to provide initial evidence of the feasibility of a waterbased exercise training augmentation for cognitive training thus laying the groundwork for full-scale clinical trials targeting the lessening of cognitive impairment in persons with amnestic MCI by non-pharmacological means.

Study Type

Interventional

Enrollment (Actual)

101

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Palo Alto, California, United States, 94304-1290
        • VA Palo Alto Health Care System, Palo Alto, CA

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Veterans aged 50 - 90
  • diagnosis of aMCI
  • available informant
  • at least one musculoskeletal problem
  • sufficient visual and auditory acuity to allow neuropsychological testing
  • willingness to participate in exercise training +cognitive training program for eight months
  • approval of primary provider to participate in an exercise trial

Exclusion Criteria:

  • current untreated severe psychiatric disorder, such as:

    • Bipolar I
    • Schizophrenia
    • or Major Depressive Disorder, determined by the Mini International Neuropsychiatric Interview (MINI)
  • diagnosis of dementia, Clinical Dementia Rating (CDR) > 0.5; modified Hachinski score 4; or delirium
  • history of neurological disorder, e.g.:

    • multiple sclerosis
    • seizure disorder
    • stroke
  • history of transient ischemic attacks, or systemic illness affecting central nervous system (CNS) function, e.g.:

    • liver failure
    • kidney failure
    • congestive heart failure
    • systemic cancer
  • acute illness or unstable chronic illness e.g., history of severe liver disease

    • cirrhosis
    • esophageal
    • varices
    • ascites
    • portal hypertension
    • hepatic encephalopathy
  • current severe cardiac disease, e.g.:

    • uncontrolled atrial fibrillation, defined as mean 24 hour heart rate >85 beats/min, or 24 hour maximal ventricular rate >150 beats/min
    • uncontrolled ventricular arrhythmias, defined as recurrent ventricular tachycardia > 3 beats in succession, or 24 hour packed cell volume (PVC) count > 20%; active
    • pericarditis or myocarditis
    • Class III/IV heart failure and / or ejection fraction < 20%
    • thrombophlebitis
    • pulmonary disease with a drop in O2 Sat with exercise to 90% without oxygen
    • embolism within past six months
  • inability to participate in an exercise stress test or inability to exercise consistently because of orthopedic or musculoskeletal problems
  • morbid obesity (BMI > 39)
  • inability to read, verbalize understanding and voluntarily sign the Informed Consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Water based Activity+ Cognitive Training
water-based physical activity + classroom based cognitive training
This is an 8 month long two phase intervention. The first phase consists of 6 months of thrice weekly pool based physical activity occurring at the Palo Alto VA Health Care System. After completion of the 6 month long water based physical activity, participants transition to a ten session cognitive training program at the Palo Alto VA. The cognitive training classes are approximately two hours in length and will be spread over ten sessions across 4 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Retention and Recruitment Rates
Time Frame: Through Study Completion, an average of 8 months
Feasibility will be demonstrated through ratio of enrolled to completed participants
Through Study Completion, an average of 8 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Delayed Recall of a Word List
Time Frame: Through Study Completion, an average of 8 months
Change From Baseline on the Delayed Recall of a Word List at 8 months
Through Study Completion, an average of 8 months
Participant Adherence to Protocol
Time Frame: Through Study Completion, an average of 8 months
Participant completion of study related measurements including pedometers, activity logs, cognitive training homework
Through Study Completion, an average of 8 months
Appropriateness of Inclusion and Exclusion Criteria
Time Frame: From time of consent until completion of Time 3 assessments, an average of 8 months
Number of reported serious and non-serious adverse events reported by participants who were eligible for study participation.
From time of consent until completion of Time 3 assessments, an average of 8 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jennifer Kaci Fairchild, PhD, VA Palo Alto Health Care System, Palo Alto, CA

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2016

Primary Completion (Actual)

April 30, 2020

Study Completion (Actual)

November 30, 2020

Study Registration Dates

First Submitted

November 23, 2015

First Submitted That Met QC Criteria

November 23, 2015

First Posted (Estimated)

November 25, 2015

Study Record Updates

Last Update Posted (Actual)

April 17, 2024

Last Update Submitted That Met QC Criteria

April 16, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • E1884-P
  • 12I1-RX001884-01A1 (Other Grant/Funding Number: Department of Veterans Affairs RRD)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mild Cognitive Impairment

Clinical Trials on Water-based Activity + Cognitive Training

Subscribe